类风湿性关节炎
化学
关节炎
药品
药理学
双氯芬酸
生物活性
生物标志物
治疗效果
药物输送
生物流体
骨关节炎
医学
关节软骨
软骨
生物医学工程
毒品携带者
生物标志物发现
功效
作者
Amol Jawarkar,Manju Makhija
摘要
Rheumatoid arthritis remains a significant therapeutic challenge requiring innovative treatment approaches that minimize systemic exposure while maximizing local efficacy1. This investigation presents a comprehensive biological evaluation of a Baricitinib-incorporated nanoemulsion gel system specifically designed for topical anti-arthritic therapy. The developed formulation underwent systematic optimization to achieve optimal physicochemical characteristics, including nanometric droplet size (186.4 nm), adequate surface charge (−31.4 mV), and sustained drug release kinetics.2,3 Biological The anti-arthritic activity was carefully examined using the formaldehyde-induced arthritis model in. Sprague–Dawley rats.4 demonstrating progressive therapeutic efficacy with 68.4% paw edema inhibition by day 21, comparable to standard diclofenac gel (72.1%). Inflammatory biomarker analysis revealed significant modulation of key mediators, with C-reactive levels of protein decreasing from 6.8-2.9 mg/L and tumor necrosis factor-alpha reducing from 128.4 to 61.4 pg/mL following treatment.5,6 Histopathological examination confirmed marked suppression of synovial inflammation, cartilage degradation, and bone erosion.7 The nanoemulsion gel system exhibited superior therapeutic outcomes compared to conventional formulations, attributed to enhanced percutaneous penetration, sustained drug delivery, and localized anti-inflammatory action.8,9 These research validate the biological anti-arthritic potential of the Baricitinibnanoemulsion gel system as a promising therapeutic strategy for rheumatoid arthritis management.
科研通智能强力驱动
Strongly Powered by AbleSci AI